FdaApplication
NDA 205580
Identifiers
- fda_app_no: NDA205580
Properties
| Property | Value |
|---|---|
| applicant_name | EAGLE PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2018-05-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BELRAPZO | BENDAMUSTINE HYDROCHLORIDE | 100MG/4ML (25MG/ML) | SOLUTION;INTRAVENOUS |
1 product